The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization

This publication has 32 references indexed in Scilit:

• Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
  The Journal Of Prevention of Alzheimer's Disease, 2025
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
  Alzheimer's & Dementia, 2024
• Donanemab in Early Symptomatic Alzheimer Disease
  JAMA, 2023
• Preparedness of China's health care system to provide access to a disease‐modifying Alzheimer's treatment
  Alzheimer's & Dementia, 2023
• National Dementia Plans of Group of Seven Countries and South Korea Based on International Recommendations
  JAMA Network Open, 2022
• 2022 Alzheimer's disease facts and figures
  Alzheimer's & Dementia, 2022
• A decade of public long-term care insurance in South Korea: Policy lessons for aging countries
  Health Policy, 2021
• The Quick Dementia Rating System (QDRS): A rapid dementia staging tool
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015
• Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
  The Lancet Neurology, 2013
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  Alzheimer's & Dementia, 2011